Edwardf Smith News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Edwardf smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Edwardf Smith Today - Breaking & Trending Today

Obituaries 05/27/2021 | Vevay Newspapers


  Deaths this week: Margaret Merrill, Robbie Kincaid, Donald Works, Don Burress.
  Switzerland County High School held its graduation ceremony for the class of 2011 on a hot, sunny Sunday afternoon, but the large crowd inside the gym witnessed a wonderful commencement.
  Jacob Chandler, who graduated form Switzerland County High School in 2008 with academic honors, has graduated from Ivy Tech College with an associates degree in Applied Science.
  Jennifer South, a 2007 graduate of Switzerland County High School has graduated from the University of Southern Indiana with a bachelor of science degree in elementary education.
  On a bright and sunny Memorial Day, a large crown of Switzerland County residents and visitors took some time to come to the Veteran’s memorial at the courthouse for annual services. ....

United States , First Presbyterian Church , Jefferson County , Bethesda Hospital , New Albany , Indiana University , Dix River , American Legion , Ohio River , Indiana State University , Northwestern University , Rising Sun , East Enterprise , Walnut Hills , Christ Hospital School Of Nursing , Switzerland County , Williamh Oatman , Jack Asbury , Edith Shaw , Wade Siebenthal , Troy Reese , Donna Cole , Richard King , Percy Buschmann , Helen Danglade , Frank Dupraz ,

Investegate |LAVA Therapeutics BV Announcements | LAVA Therapeutics BV: LAVA Therapeutics Provides Business Update and Reports First Quarter Financial Results


LAVA Therapeutics Provides Business Update and Reports First Quarter Financial Results
IPO bolsters balance sheet to $160 million in cash and cash equivalents; expected to fund operations at least into the second half of 2023
Clinical development plans on schedule in both hematological and solid tumor programs
Leadership strengthened through key management and board appointments
UTRECHT, The Netherlands and PHILADELPHIA, May 20, 2021 (GLOBE NEWSWIRE) LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in gamma-delta bispecific T cell engagers (bsTCEs) to transform cancer therapy, today reported its business update and first quarter 2021 financial results.
“We continue to make important strides across all aspects of our business as we transition to a clinical stage organization,” said Stephen Hurly, chief executive officer of LAVA Therapeutics. “With the recent additions to our leadership team and board and ....

United States , Edwardf Smith , Angion Biomedica , Chelcie Lister , Karen Wilson , Kapil Dhingra , Janssen Biotech Inc , Benitec Biopharma Inc , Replimune Inc , Jazz Pharmaceuticals , Audit Committee , Leadership Team , Marinus Pharmaceuticals , Strategic Communications , American Association For Cancer Research , Diamond Therapeutics Inc , Therapeutics Inc , Vaxart Inc , Provides Business Update , Reports First Quarter Financial , Stephen Hurly , Clinical Trial , Multiple Hematological Malignancies , Data Supporting Anti Tumor Activity , American Association , Cancer Research ,

LAVA Therapeutics BV: LAVA Therapeutics Provides Business Update and Reports First Quarter Financial Results


LAVA Therapeutics BV: LAVA Therapeutics Provides Business Update and Reports First Quarter Financial Results
Clinical development plans on schedule in both hematological and solid tumor programs
Leadership strengthened through key management and board appointments
UTRECHT, The Netherlands and PHILADELPHIA, May 20, 2021 (GLOBE NEWSWIRE) LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in gamma-delta bispecific T cell engagers (bsTCEs) to transform cancer therapy, today reported its business update and first quarter 2021 financial results.
We continue to make important strides across all aspects of our business as we transition to a clinical stage organization, said Stephen Hurly, chief executive officer of LAVA Therapeutics. With the recent additions to our leadership team and board and the proceeds from our IPO, we are well-positioned to advance our pipeline as we work toward our mission of transforming cancer th ....

United States , Edwardf Smith , Angion Biomedica , Chelcie Lister , Karen Wilson , Kapil Dhingra , Janssen Biotech Inc , Benitec Biopharma Inc , Replimune Inc , Jazz Pharmaceuticals , Audit Committee , Leadership Team , Marinus Pharmaceuticals , Strategic Communications , American Association For Cancer Research , Diamond Therapeutics Inc , Therapeutics Inc , Vaxart Inc , Stephen Hurly , Clinical Trial , Multiple Hematological Malignancies , Data Supporting Anti Tumor Activity , American Association , Cancer Research , Initial Public Offering Completed , Team Strengthened ,